[Influence of walking training on haemoglobin glucosile and fasting blood sugar levels in women with type 2 diabetes]

ABSTRACT

Physical activities are as one of the basic element for curing diabetes. Walking can be considered as one of the physical activities, which it doesn't need any special equipments and can be part of daily life of those have diabetes. Therefore, the aim of this research was to examine the effects of walking training on haemoglobin glucosile and fasting blood sugar levels in women with type 2 diabetes. This quasi-experimental interventional study was carried out on 88 women who suffered from type 2 diabetes. The data was collected using a questionnaire including demographic information, performance regarding the appropriate or correct walking and also a checklist about the amount of walking and also levels of fasting blood sugar [FBS] and hemoglobin glycosides [HbA1c] of the patients. The data was collected prior to starting interfering training. Then the interfering training was applied for the intervention group in 4 educational sessions and each one for 60 minutes during one month. Three months following the training. The data and levels of FBS and HbA1c were again collected and measured from the patients. Before training, the intervention and control groups scores of cooest walking performance was less than average and the most part of their walking was a type of light walking [%77.86 and%74.4 in intervention and control groups, respectively]. In addition, the levels of FBS and HbA1c in the patient were higher than the normal levels. Following the intervention, mean of correct walking performance and also the times spent on walking with average and heavy extents were significantly increased in the intervention group as compared with control one [P<0.0001]. Moreover, levels of FBS and HbA1c of the intervention group were significantly reduced as compared with the control group [P<0.0001]. Our findings indicate that walking education is an important method for control of FBS and HbA1c levels in patients with type 2 diabetes